| J9271 | Injection, pembrolizumab, 1 mg | 17,200 | $40 | $739.6K |
| J0897 | Injection, denosumab, 1 mg | 4,740 | $20 | $90.1K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 77,250 | $1 | $77.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 660 | $100 | $67.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 10,340 | $10 | $62K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 330 | $140 | $46.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $110 | $33.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 460 | $70 | $32K |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 3,580 | $10 | $25K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 160 | $150 | $23.1K |